Back to Search
Start Over
Comparison of vancomycin area under the concentration-time curve (AUC) using two-point pharmacokinetics versus two open-access online single-concentration vancomycin calculators.
- Source :
-
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Dec; Vol. 47 (12), pp. 2223-2229. Date of Electronic Publication: 2022 Nov 09. - Publication Year :
- 2022
-
Abstract
- What Is Known and Objective: Current vancomycin monitoring guidelines recommend the use of area under the concentration-time curve (AUC <subscript>24</subscript> ) monitoring in patients with serious Methicillin-Resistant Staphylococcus aureus (MRSA) infections by utilizing either a Bayesian approach or first-order analytic equations. Several open-access websites exist that allow estimation of vancomycin AUC <subscript>24</subscript> with the use of a single steady-state concentration. It is uncertain how these open-access calculators perform against guideline-recommended methods. The objective was to compare AUC <subscript>24</subscript> estimates from two online, open-access, single-concentration vancomycin calculators compared with the two-point pharmacokinetic (2PK) method.<br />Methods: AUC <subscript>24</subscript> estimates were made using the 2PK reference method and the single-concentration vancomycin calculators, ClinCalc and VancoPK. The AUC <subscript>24</subscript> estimates from the 2PK reference method were compared to the online calculators by assessing bias (median AUC <subscript>24</subscript> difference) and precision (AUC <subscript>24</subscript> difference ± 100 mg*h/L). Clinical precision was also assessed by characterizing the frequency that the 2PK reference method and the online calculators showed clinical disagreement based on the following AUC <subscript>24</subscript> categories: (1) AUC <subscript>24</subscript> < 400 mg*h/L; (2) AUC <subscript>24</subscript> 400-600 mg*h/L and (3) AUC <subscript>24</subscript> > 600 mg*h/L.<br />Results and Discussion: A total of 253 patients were included in the study. The AUC <subscript>24</subscript> estimates from the ClinCalc and VancoPK single-concentration vancomycin calculators showed some bias and imprecision, though VancoPK appeared to have less. Clinical disagreement versus the 2PK reference method occurred in 31.2% and 19.4% of AUC <subscript>24</subscript> estimates from the ClinCalc and VancoPK single-concentration vancomycin calculators, suggesting clinical imprecision.<br />What Is New and Conclusion: The AUC <subscript>24</subscript> estimates from single-concentration, online vancomycin calculators showed some bias and imprecision in comparison to the 2PK method. Institutions should validate these online, trough-only calculators relative to a 2PK method in their patient populations prior to adoption as standard-of-care.<br /> (© 2022 John Wiley & Sons Ltd.)
Details
- Language :
- English
- ISSN :
- 1365-2710
- Volume :
- 47
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Journal of clinical pharmacy and therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 36351763
- Full Text :
- https://doi.org/10.1111/jcpt.13795